Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Subcutaneous Administration Subcutaneous injection represents the most practical route for self-administration of BPC-157
- Tablet excipients
D., Pandey, B
Per week: 14 swabs (2/day) 8 weeks: 112 swabs recommend 2 100-count boxes 12 weeks: 168 swabs recommend 2 100-count boxes 16 weeks: 224 swabs recommend 3 100-count boxes Protocol Overview Goal: Enhance skin pigmentation via melanocortin receptor activation Schedule: Daily injections for 68 weeks (loading phase) Maintenance: 12 injections per week Dose Range: 250500 mcg daily Cycle Length: 812 weeks typical Dosing Protocol Start at 250 mcg daily Increase gradually every 12 weeks Transition to maintenance dosing after initial phase Inject at a consistent time and rotate sites Storage Instructions Lyophilized: Store at 20C in a dry, dark environment Reconstituted: Refrigerate at 28C Avoid repeated freezethaw cycles Use within 23 weeks for best stability Allow vial to reach room temperature before opening Important Notes Key considerations for consistency, handling, and research accuracy
In *SURMOUNT-MAINTAIN*, Eli Lilly randomized patients who reached goal weight on their maximum tolerated tirzepatide dose into three arms: continue at max dose, step down to 5 mg, or switch to placebo
US$ 21.58
US$ 25.42
US$ 21.27
US$ 25.63
US$ 27.01
